← FDA DRUG APPROVALS

FDA ANDA · ANDA076665

FLUCONAZOLE

Sponsor: CHARTWELL

APPLICATION
ANDA076665
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-29
LATEST ACTION
2020-06-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FLUCONAZOLEPrescription
FLUCONAZOLE 150MG · TABLET · ORAL
FLUCONAZOLEPrescription
FLUCONAZOLE 50MG · TABLET · ORAL
FLUCONAZOLEPrescription
FLUCONAZOLE 200MG · TABLET · ORAL
FLUCONAZOLEPrescription
FLUCONAZOLE 100MG · TABLET · ORAL

Approval history

2020-06-22Labeling · Supplement 10 · standardAP
2020-06-22Labeling · Supplement 9 · standardAP
2020-06-22Labeling · Supplement 11 · standardAP
2015-03-14Labeling · Supplement 7 · standardAP
2015-03-14Labeling · Supplement 8 · standardAP
2015-03-14Labeling · Supplement 6 · standardAP
2005-05-27Labeling · Supplement 1AP
2004-07-29OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →